Results 131 to 140 of about 6,726,151 (303)

King Fellow Address 2017

open access: yes, 2017
King Fellow Address given by 2016 King Fellow Dr.
May, Ruth
core  

A. S. Pushkin’s Address “To a Kalmyk Maiden”: Aspects of Genre Originality

open access: yesOriental Studies, 2018
The main feature of the genre of the poetic form in question is an appeal to the addresses. The article defines the typology of addresses, including addresses to a recipient who is by default unable to response - as in A.S. Pushkin’s Address “To a Kalmyk
B. Kichikova
doaj  

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

open access: yesMolecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary   +1 more
wiley   +1 more source

King Fellow Address 2014

open access: yes, 2014
King Fellow Address given by 2013 King Fellow Dr.
Hicks, Sally
core  

IPv6 Dynamic Address Tunnel Model Based on the Sliding Address Window

open access: yesDianxin kexue, 2015
IPv6 network address hopping transmission technology can effectively prevent network attacks through traffic analysis.On the basis of the study of some related technologies,the concept of dynamic address chain was applied to the IPv6 network address ...
Zichuan Ma   +3 more
doaj   +2 more sources

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

King Fellow Address 2013

open access: yes, 2013
King Fellow Address given by 2012 King Fellow Dr.
Sullivan, Charles
core  

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

Factors motivating maternal healthcare clients to use mHealth interventions in rural Malawi.

open access: yesPLOS Digital Health
Client-facing mHealth interventions have the potential to address the inequalities in accessing health information. In maternal healthcare, mHealth interventions provide information to pregnant women on how they can stay healthy during pregnancy, as well
Priscilla Maliwichi   +2 more
doaj   +1 more source

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy